Robeco Institutional Asset Management B.V. Has $114.97 Million Position in Cardinal Health, Inc. (NYSE:CAH)

Robeco Institutional Asset Management B.V. boosted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 4.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 972,060 shares of the company’s stock after purchasing an additional 39,767 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.40% of Cardinal Health worth $114,966,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Eastern Bank acquired a new stake in Cardinal Health in the 3rd quarter valued at $25,000. Frazier Financial Advisors LLC lifted its stake in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after acquiring an additional 104 shares in the last quarter. Hara Capital LLC bought a new position in Cardinal Health during the 3rd quarter valued at $31,000. AM Squared Ltd bought a new position in Cardinal Health during the 3rd quarter valued at $33,000. Finally, Carolina Wealth Advisors LLC bought a new position in Cardinal Health during the 3rd quarter valued at $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Down 2.4 %

CAH stock opened at $127.59 on Wednesday. The firm has a market capitalization of $30.88 billion, a PE ratio of 24.82, a PEG ratio of 1.57 and a beta of 0.63. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $131.29. The stock has a 50-day simple moving average of $121.75 and a two-hundred day simple moving average of $113.66.

Cardinal Health (NYSE:CAH) last posted its earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same quarter in the previous year, the firm earned $1.73 EPS. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s payout ratio is 39.30%.

Analysts Set New Price Targets

Several equities analysts have weighed in on CAH shares. Citigroup raised their price objective on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. Mizuho started coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective on the stock. Barclays lifted their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Finally, JPMorgan Chase & Co. lifted their target price on Cardinal Health from $132.00 to $142.00 and gave the stock a “neutral” rating in a research note on Friday, January 24th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $135.21.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.